Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multiple myeloma and other plasma cell neoplasms. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in multiple myeloma and other plasma cell neoplasms that are not listed here.
Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
- Alkeran for Injection (Melphalan Hydrochloride)
- Alkeran Tablets (Melphalan)
- Aredia (Pamidronate Disodium)
- BiCNU (Carmustine)
- Bortezomib
- Carfilzomib
- Carmustine
- Cyclophosphamide
- Daratumumab
- Darzalex (Daratumumab)
- Doxil (Doxorubicin Hydrochloride Liposome)
- Doxorubicin Hydrochloride Liposome
- Elotuzumab
- Empliciti (Elotuzumab)
- Evomela (Melphalan Hydrochloride)
- Farydak (Panobinostat)
- Isatuximab-irfc
- Ixazomib Citrate
- Kyprolis (Carfilzomib)
- Lenalidomide
- Melphalan
- Melphalan Hydrochloride
- Mozobil (Plerixafor)
- Ninlaro (Ixazomib Citrate)
- Pamidronate Disodium
- Panobinostat
- Plerixafor
- Pomalidomide
- Pomalyst (Pomalidomide)
- Revlimid (Lenalidomide)
- Sarclisa (Isatuximab-irfc)
- Selinexor
- Thalidomide
- Thalomid (Thalidomide)
- Velcade (Bortezomib)
- Xpovio (Selinexor)
- Zoledronic Acid
- Zometa (Zoledronic Acid)